LLY

1,010.53

-2.15%↓

JNJ

202.19

-1.57%↓

ABBV

228.68

-0.7%↓

UNH

333.72

-1.99%↓

AZN

89.97

-0.96%↓

LLY

1,010.53

-2.15%↓

JNJ

202.19

-1.57%↓

ABBV

228.68

-0.7%↓

UNH

333.72

-1.99%↓

AZN

89.97

-0.96%↓

LLY

1,010.53

-2.15%↓

JNJ

202.19

-1.57%↓

ABBV

228.68

-0.7%↓

UNH

333.72

-1.99%↓

AZN

89.97

-0.96%↓

LLY

1,010.53

-2.15%↓

JNJ

202.19

-1.57%↓

ABBV

228.68

-0.7%↓

UNH

333.72

-1.99%↓

AZN

89.97

-0.96%↓

LLY

1,010.53

-2.15%↓

JNJ

202.19

-1.57%↓

ABBV

228.68

-0.7%↓

UNH

333.72

-1.99%↓

AZN

89.97

-0.96%↓

Search

Simulations Plus Inc

Cerrado

SectorSanidad

20.42 0.64

Resumen

Variación precio

24h

Actual

Mínimo

20.15

Máximo

20.74

Métricas clave

By Trading Economics

Ingresos

-70M

-67M

Ventas

-2.1M

20M

P/B

Media del Sector

48.528

80.03

Rentabilidad por dividendo

0.48

Margen de beneficios

-330.585

Empleados

243

EBITDA

327K

5.3M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+0.74% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.29%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-7M

344M

Apertura anterior

19.78

Cierre anterior

20.42

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

178 / 374 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

4 dic 2025, 20:41 UTC

Ganancias
Principales Movimientos del Mercado

America's Car-Mart Rises on Better-Than-Expected 2Q Revenue, $300 Million Term Loan

4 dic 2025, 18:14 UTC

Adquisiciones, fusiones, absorciones

Big Yellow Says It Will Terminate Takeover Talks With Blackstone

4 dic 2025, 17:43 UTC

Principales Movimientos del Mercado
Adquisiciones, fusiones, absorciones

Brera Holdings Signs Non-Binding Term Sheet to Acquire RockawayX

4 dic 2025, 17:01 UTC

Ganancias

TD Bank Pushes Up Dividend After Underlying Earnings, Revenue Beat Expectations -- Update

4 dic 2025, 23:45 UTC

Charlas de Mercado

Nikkei May Decline Amid Caution Over U.S. Labor Market, Japan Earnings -- Market Talk

4 dic 2025, 23:45 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

4 dic 2025, 21:54 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

4 dic 2025, 21:54 UTC

Charlas de Mercado

Warehouse's Strategy to Lift Margins Easier Said Then Done -- Market Talk

4 dic 2025, 21:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

4 dic 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

4 dic 2025, 21:48 UTC

Charlas de Mercado

Scales Hits Mark With Earnings Guidance -- Market Talk

4 dic 2025, 21:37 UTC

Ganancias

Aerospace Start-Up Beta Posts Its First Earnings Report. The Stock Rises. -- Barrons.com

4 dic 2025, 21:36 UTC

Ganancias

These Stocks Moved the Most Today: Meta Platforms, Salesforce, Snowflake, UiPath, Micron, Dollar General, Kroger, and More -- Barrons.com

4 dic 2025, 20:15 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

4 dic 2025, 20:15 UTC

Charlas de Mercado

Think Tank Calls For Bank of Canada Rate Hold Next Week -- Market Talk

4 dic 2025, 20:04 UTC

Charlas de Mercado

Natural Gas Futures Extend Gains as U.S. Grows Cold -- Market Talk

4 dic 2025, 19:54 UTC

Charlas de Mercado

Oil Futures Bolstered by Lasting Ukraine War, U.S. Macro Outlook -- Market Talk

4 dic 2025, 19:44 UTC

Adquisiciones, fusiones, absorciones

EQB CEO: PC Financial Deal Adds Scale to Compete With Larger Canadian Banks

4 dic 2025, 19:44 UTC

Adquisiciones, fusiones, absorciones

EQB CEO: PC Financial Tie-Up Brings Scale to Reach More Customers

4 dic 2025, 19:44 UTC

Adquisiciones, fusiones, absorciones

Equitable Bank Deal for PC Financial Adds Heft to Compete With Canada's Big Banks -- Interview

4 dic 2025, 19:33 UTC

Charlas de Mercado

Gold Inches Higher as Traders Continue to Mull ADP Jobs Report -- Market Talk

4 dic 2025, 19:01 UTC

Adquisiciones, fusiones, absorciones

Paramount Raises Concerns About Netflix's Bid for Warner Bros. Discovery -- WSJ

4 dic 2025, 19:01 UTC

Adquisiciones, fusiones, absorciones

Paramount Wrote to Warner Bros. Discovery Again Wednesday -- WSJ

4 dic 2025, 19:01 UTC

Adquisiciones, fusiones, absorciones

Paramount Wrote Netflix Deal With Warner Bros. Would Likely 'Never Close,' Monday Letter Says -- WSJ

4 dic 2025, 19:01 UTC

Adquisiciones, fusiones, absorciones

Another Round of Bids for Warner Bros. Discovery Due Thursday, Sources Say -- WSJ

4 dic 2025, 18:58 UTC

Charlas de Mercado

U.S.-Venezuela Military Tension Expected to Lift Oil Prices -- Market Talk

4 dic 2025, 17:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

4 dic 2025, 17:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

4 dic 2025, 16:41 UTC

Charlas de Mercado

Gold Rises as Traders Await U.S. Inflation Data -- Market Talk

4 dic 2025, 16:33 UTC

Charlas de Mercado
Ganancias

Salesforce Customers Are Gaining Confidence in Agentforce -- Market Talk

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

0.74% repunte

Estimación a 12 Meses

Media 20.5 USD  0.74%

Máximo 25 USD

Mínimo 16 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

3

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

178 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat